Prozac (fluoxetine) can be taken while breastfeeding, but it’s not the top choice among antidepressants for nursing mothers. It does pass into breast milk, and compared to similar medications, it’s more likely to build up in a breastfed infant’s system. That said, many women have breastfed on fluoxetine without any problems, and six-month follow-up studies show normal weight gain and neurological development in exposed infants.
How Much Reaches Your Baby
Fluoxetine transfers into breast milk at what’s called a relative infant dose (RID) of about 6%. That’s under the 10% threshold generally considered acceptable for breastfeeding medications, but it’s higher than most other antidepressants in the same class. In one breast milk sample, the combined concentration of fluoxetine and its breakdown product was about 70 ng/mL, compared to 295 ng/mL in the mother’s blood.
What makes fluoxetine different from other options is how slowly the body clears it. In adults, the drug itself takes 4 to 6 days to leave the system with regular use, and its active breakdown product lingers for 9 to 10 days on average. Newborns process drugs even more slowly, which means fluoxetine can accumulate over time. In one study of 20 nursing infants, the breakdown product was detectable in the blood of 85% of them, and the drug itself was detectable in 30%.
Babies who were also exposed to fluoxetine during pregnancy tend to have higher levels after birth, because the drug is already in their system before breastfeeding begins. For infants with only breastfeeding exposure, levels are typically lower.
Possible Side Effects in Infants
Most breastfed infants whose mothers take fluoxetine show no side effects at all. When problems do occur, they’re generally mild. Occasional reports include jitteriness, restlessness, poor feeding, diarrhea, sleep disturbances, and drowsiness. Sedation is one symptom that has only been linked to breast milk exposure specifically, rather than withdrawal from prenatal exposure.
In the early days after birth, it can be hard to tell whether a fussy baby is reacting to the medication in breast milk or simply going through withdrawal from prenatal exposure. Both can cause similar symptoms: agitation, jitteriness, low muscle tone, and stomach upset. If symptoms persist beyond the first few days of life, the breast milk exposure is more likely the cause.
Premature infants may be at higher risk for side effects because their livers and kidneys are even less mature, making them slower to clear the drug. One documented case of toxicity in a preterm baby involved tremor, shivering, irritability, and temperature changes, though that case involved a different antidepressant and a genetic factor that slowed the baby’s metabolism further.
What to Watch For
If you’re breastfeeding while taking fluoxetine, keep an eye on your baby for changes in feeding patterns, unusual fussiness or restlessness, excessive sleepiness, trouble sleeping, and digestive issues like diarrhea or vomiting. Weight gain is also worth tracking. These signs don’t mean you need to stop breastfeeding or stop your medication, but they’re worth flagging to your pediatrician so you can figure out the cause together.
Long-Term Development
The reassuring news is that studies following infants exposed to fluoxetine through breast milk have not found developmental problems. In one study published in The British Journal of Psychiatry, researchers repeatedly assessed cognitive and motor development using standardized scales. All infants developed normally and showed no abnormal neurological findings. Six-month follow-up data from broader reviews of SSRI exposure during breastfeeding confirm normal weight gain and neurological development.
How Fluoxetine Compares to Other Options
Among antidepressants commonly prescribed to breastfeeding mothers, fluoxetine consistently produces the highest infant blood levels. Sertraline, paroxetine, and fluvoxamine result in essentially undetectable levels in infant blood, even though sertraline actually has a higher milk-to-plasma ratio (1.0 to 2.0, compared to fluoxetine’s 0.5 to 0.8). The difference comes down to how each drug behaves once ingested: fluoxetine’s slow clearance allows it to accumulate in the infant, while sertraline is processed and eliminated much more quickly.
For this reason, sertraline is often the first-choice antidepressant for breastfeeding mothers starting a new medication. Paroxetine and escitalopram are also considered good options based on their low infant exposure profiles.
When Fluoxetine Still Makes Sense
If fluoxetine is the medication that effectively manages your depression or anxiety, switching to a different antidepressant solely because you’re breastfeeding isn’t always the right call. Changing medications means a transition period where you may not be fully treated, and undertreated depression carries its own risks for both you and your baby. The NHS guidance puts it plainly: other medicines that pass into breast milk in smaller amounts might be preferred, but it’s important you take the medicine that works for you.
Women who were stable on fluoxetine throughout pregnancy often continue it while breastfeeding rather than risk a relapse by switching. The overall exposure through breast milk is much lower than what the baby received in utero, so in many cases, breastfeeding actually represents a step down in exposure. The key is balancing the small, manageable risks of infant exposure against the very real benefits of effective treatment for postpartum depression and the well-established benefits of breastfeeding itself.